About Speaker: Duncan Mackie, PhD, Director of Pharmacology & Experimental Therapeutics, MedPharm Holdings Event Description: Alzheimer’s disease remains one of the most challenging neurodegenerative conditions to treat, and interest is growing in how cannabinoids might modulate key pathways involved in its progression. MedPharm Holdings, a Denver-based cannabis research and formulation development company, has focused its...